Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$9.84 - $20.13 $1.97 Million - $4.03 Million
-200,000 Reduced 44.44%
250,000 $3.79 Million
Q2 2023

Aug 11, 2023

SELL
$17.41 - $30.05 $2.61 Million - $4.51 Million
-150,000 Reduced 25.0%
450,000 $12.7 Million
Q1 2023

May 09, 2023

SELL
$16.14 - $24.94 $2.42 Million - $3.74 Million
-150,000 Reduced 20.0%
600,000 $10.3 Million
Q4 2022

Feb 13, 2023

BUY
$18.07 - $25.6 $3.61 Million - $5.12 Million
200,000 Added 36.36%
750,000 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$20.23 - $31.73 $4.24 Million - $6.66 Million
209,757 Added 61.65%
550,000 $11.9 Million
Q2 2022

Aug 03, 2022

BUY
$17.91 - $52.25 $2.24 Million - $6.54 Million
125,243 Added 58.25%
340,243 $9.56 Million
Q1 2022

May 12, 2022

BUY
$41.58 - $80.89 $3.95 Million - $7.68 Million
95,000 Added 79.17%
215,000 $9.92 Million
Q4 2021

Feb 02, 2022

BUY
$66.92 - $84.79 $2.01 Million - $2.54 Million
30,000 Added 33.33%
120,000 $10.1 Million
Q3 2021

Nov 12, 2021

SELL
$46.83 - $73.5 $1.64 Million - $2.57 Million
-35,000 Reduced 28.0%
90,000 $6 Million
Q2 2021

Aug 30, 2021

SELL
$37.41 - $62.25 $4.68 Million - $7.78 Million
-125,000 Reduced 50.0%
125,000 $6.65 Million
Q2 2021

Aug 13, 2021

BUY
$37.41 - $62.25 $7.86 Million - $13.1 Million
210,000 Added 525.0%
250,000 $13.3 Million
Q1 2021

May 10, 2021

BUY
$35.69 - $52.72 $1.43 Million - $2.11 Million
40,000 New
40,000 $1.74 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $171M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.